Truist Financial
BVS icon

Truist Financial’s Bioventus BVS Stock Holding History

Truist Financial’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
13,095
+615
+5% +$5.87K ﹤0.01% 2834
2026
Q1 		$114K Hold
12,480
– – ﹤0.01% 2708
2025
Q4 		$92.9K Buy
+12,480
New +$89.7K ﹤0.01% 2681

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Truist Financial's BVS Position: Q2 2026 in Review

Truist Financial increased its Bioventus (BVS) stake by 4.9% in Q2 2026, buying an estimated $5.87K and bringing the position to 13,095 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

Truist Financial first reported a position in BVS in Q4 2025 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Truist Financial held 13,095 shares of Bioventus worth $124K as of Q2 2026.
  • Truist Financial bought 615 Bioventus shares in Q2 2026, an estimated $5.87K.
  • Bioventus made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2834 holding.
  • Truist Financial first reported a position in Bioventus in Q4 2025 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.